Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M862Revenue $M14.2Net Margin (%)-730.7Z-Score11.7
Enterprise Value $M584EPS $-3.3Operating Margin %-731.8F-Score4
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-458.9Higher ROA y-yY
Price/Book2.910-y EBITDA Growth Rate %-9.1Quick Ratio10.4Cash flow > EarningsY
Price/Sales50.85-y EBITDA Growth Rate %25.2Current Ratio10.4Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-40.6Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-50.8Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M40.7ROI % (ttm)-300.9Gross Margin Increase y-yN

Gurus Latest Trades with SRPT

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SRPTGeorge Soros 2014-06-30 Add0.14%$22.18 - $38.91
($31.64)
$ 21.13-33%Add 2620%680,000
SRPTGeorge Soros 2014-03-31 Reduce-0.04%$17.91 - $30.29
($25.36)
$ 21.13-17%Reduce -89.27%25,000
SRPTGeorge Soros 2013-12-31 Reduce-0.22%$12.89 - $53.81
($29.58)
$ 21.13-29%Reduce -64.98%233,000
SRPTGeorge Soros 2013-09-30 Add0.12%$30.906 - $47.97
($38.37)
$ 21.13-45%Add 56.28%665,274
SRPTGeorge Soros 2013-03-31 Add0.08%$23.97 - $36.95
($28.83)
$ 21.13-27%Add 82.54%413,329
SRPTGeorge Soros 2012-12-31 Add0.05%$14.99 - $44.93
($26.74)
$ 21.13-21%Add 184.13%226,429
SRPTJean-Marie Eveillard 2012-03-31 Sold Out $4.5 - $9.6
($6.06)
$ 21.13249%Sold Out0
SRPTJean-Marie Eveillard 2011-12-31 Reduce$3.24 - $6.54
($5.04)
$ 21.13319%Reduce -83.33%50,000
SRPTJean-Marie Eveillard 2011-09-30 Add$6.3 - $9.9
($7.92)
$ 21.13167%Add 50%300,000
SRPTJean-Marie Eveillard 2011-06-30 Buy $8.1 - $11.22
($9.66)
$ 21.13119%New holding, 200000 sh.200,000
SRPTGeorge Soros 2006-03-31 Buy 0.08%$24.54 - $50.45
($41.39)
$ 21.13-49%New holding, 308100 sh.308,100
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SRPT is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
SRPT George Soros 2014-06-30680,0001.670.15+2620%
Premium Most recent portfolio changes are included for Premium Members only!


SRPT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
CHASE ANTHONY RDirector 2013-11-14Buy10,000$13.9551.47view
Aphale JayantSVP Technical Operations 2013-11-12Sell15,933$12.5668.23view
BEHRENS M KATHLEENDirector 2013-09-16Buy6,500$37.04-42.95view
HODGMAN JOHNDirector 2013-09-03Sell5,556$34.97-39.58view
CHASE ANTHONY RDirector 2013-08-22Buy3,500$32.68-35.34view
Mahatme SandeshSenior Vice President, CFO 2013-08-20Buy5,000$31.1-32.06view
Price Ben GilDirector 2013-08-19Buy500$31.18-32.23view
CHASE ANTHONY RDirector 2013-06-14Buy10,000$38.5-45.12view
CHASE ANTHONY RDirector 2012-11-28Sell10,000$29.46-28.28view
CHASE ANTHONY RDirector 2012-11-14Sell10,000$25.7-17.78view

Press Releases about SRPT :

    Quarterly/Annual Reports about SRPT:

    News about SRPT:

    Articles On GuruFocus.com
    Insiders Are Buying Fate Therapeutics Oct 09 2013 
    comment on SRPT Mar 16 2013 
    comment on SRPT Mar 16 2013 
    comment on SRPT Feb 16 2013 

    More From Our Partners
    Sarepta Reports Favorable Safety Results from Phase I Study of AVI-7100 Sep 30 2014 - BENZINGA

    More From Other Websites
    Shares of companies testing Ebola vaccines rise Sep 30 2014
    [audio] Newscast: Wall Street notches winning quarter Sep 30 2014
    U.S. considering experimental drugs for Texas Ebola patient -CDC Sep 30 2014
    [video] CDC: Will identify contacts of US Ebola patient Sep 30 2014
    CDC: Will identify contacts of US Ebola patient Sep 30 2014
    First Ebola case diagnosed in the United States -CDC Sep 30 2014
    CDC's Ebola strategy Sep 30 2014
    [video] CDC's Ebola strategy Sep 30 2014
    [video] Tex. Health Commissioner: Committed to keeping Texans safe Sep 30 2014
    Tex. Health Commissioner: Committed to keeping Texans saf... Sep 30 2014
    [video] CDC: Individual traveling from Liberia diagnosed with Ebola in US Sep 30 2014
    CDC: Individual traveling from Liberia diagnosed with Ebo... Sep 30 2014
    Awaiting CDC news conference Sep 30 2014
    [video] Awaiting CDC news conference Sep 30 2014
    [video] Sarepta CEO ready with Ebola drug if requested Sep 30 2014
    Sarepta CEO ready with Ebola drug if requested Sep 30 2014
    [video] Texas officials: Patient's symptoms began days after US return Sep 30 2014
    Texas officials: Patient's symptoms began days after US r... Sep 30 2014
    [video] Pharma companies spike ahead of CDC newser Sep 30 2014
    Pharma companies spike ahead of CDC newser Sep 30 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK